Colby v. Assurant Employee Benefits

603 F. Supp. 2d 223, 2009 U.S. Dist. LEXIS 24419, 2009 WL 756974
CourtDistrict Court, D. Massachusetts
DecidedFebruary 23, 2009
DocketCivil Action 07-11488-RCL
StatusPublished
Cited by8 cases

This text of 603 F. Supp. 2d 223 (Colby v. Assurant Employee Benefits) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Colby v. Assurant Employee Benefits, 603 F. Supp. 2d 223, 2009 U.S. Dist. LEXIS 24419, 2009 WL 756974 (D. Mass. 2009).

Opinion

MEMORANDUM OF DECISION

YOUNG, District Judge.

I. INTRODUCTION

This is an action under the Employment Retirement Security Act of 1974, codified as amended at 29 U.S.C. §§ 1001-1461 (ERISA). The plaintiff, Dr. Julie Colby, M.D. (“Dr. Colby”), filed suit against the defendants, Assurant Employee Benefits, Fortis Benefits Insurance Company, Management Company for Merrimack Anesthesia Associates Long Term Disability Plan, and Union Security Insurance Company and Management Company for Merrimack Anesthesia Associates Long Term Disability Plan (collectively “USIC”), to recover long-term disability (“LTD”) benefits she claims that USIC denied her in violation of 29 U.S.C. § 1132(a)(1)(B), as well as attorneys’ fees and costs. In 2004, Dr. Colby, then an anesthesiologist, became addicted to Fentanyl, a powerful opioid that she administered to patients, as a means of coping with severe back pain. After the discovery of her addiction by eoworkers, Dr. Colby stopped working, had her medical license revoked, and enrolled into an in-patient substance abuse recovery program. At that time, Dr. Colby also applied for LTD benefits under her LTD policy (“the Plan” or “the LTD Plan”) with USIC, which USIC granted for the duration of Dr. Colby’s stay at the rehabilitation center. Upon her discharge, however, USIC terminated her benefits. Claiming that Dr. Colby no longer had symptoms of active substance abuse, USIC’s primary justification for the termination was that “the risk of relapse [into substance abuse] is not the same as a current disability.” In other words, USIC categorically excluded risk of relapse into drug abuse as an impairment that could ever render an individual disabled such that he or she would be eligible for benefits under the Plan. After twice unsuccess *226 fully appealing USIC’s determination and challenging its interpretation of the Plan, Dr. Colby instituted these federal proceedings in 2007, claiming that USIC’s termination of her benefits was arbitrary and capricious.

The parties filed cross motions for summary judgment, and then agreed to resolve their dispute as a case stated. “When deciding a case stated, a court draws such inferences as are reasonable to resolve the case, rather than drawing all inferences against each moving party as it would when evaluating cross-motions for summary judgment.” Dickerson v. Prudential Life Ins. Co. of Am., 574 F.Supp.2d 239, 241 (D.Mass.2008) (quotation marks and citation omitted); See Bunch v. W.R. Grace & Co., 555 F.3d 1, 3 n. 4 (1st. Cir.2009).

II. FINDINGS OF FACT

A. Dr. Colby’s History of Back Issues and the Onset of Her Substance Abuse

In 1988, Dr. Colby, a native of Canada, moved to the United States and became a partner at the Merrimack Valley Anesthesia Associates. US 1 524. Through her practice, Dr. Colby worked as a staff anesthesiologist at the Anna Jacques Hospital in Newburyport, Massachusetts. Id. Dr. Colby worked approximately 60 to 90 hours per week, and took overnight calls approximately 2-3 times per week. Id. Between 1988 and August 2004, Dr. Colby never missed a day of work. US 525.

Beginning in the summer of 2000, Dr. Colby began experiencing lower back pain and numbness in her left leg. Id. The problems with her leg initially caused her to trip clumsily, but by June 2000, her left calf muscle ceased functioning. US 525-26. Doctors diagnosed Dr. Colby with a herniated disc at L5-S1, and she underwent a discectomy in September 2001. US 526. The surgery allowed Dr. Colby to regain use of her left calf muscle, but her back pain and some left leg numbness persisted. Id. According to Dr. Colby, because of her continuing symptoms, she began to self-medicate using Fentanyl, a powerful opioid, left over from surgeries in the operating room. US 444, 527. Within a short time period, Dr. Colby became addicted to and dependent on Fentanyl.

In April 2004, Dr. Colby sought the advice of Dr. Paul Glazer (“Dr. Glazer”), a spinal surgeon, who diagnosed Dr. Colby with degenerative disc disease at several places along her spine. US 526. Dr. Glazer recommended spinal fusion surgery, but Dr. Colby refused because she was concerned about losing her position in her medical practice. Id.

In July 2004, an employee of Dr. Colby’s practice discovered her sleeping or unconscious on a nursing staff table in the hall of the hospital. US 444. The head of the anesthesia group requested a urine drug screen, which was positive for Fentanyl. Id. Dr. Colby voluntarily relinquished her license to practice medicine in August of 2004, and formally had her license revoked in July 2005.

B. Dr. Colby’s Substance Abuse Treatment

On August 16, 2004, upon recommendation of the Massachusetts Physician’s Health Services, Dr. Colby enrolled herself in the Talbott Recovery Campus in Atlanta, Georgia, a facility that specializes in treating doctors with substance abuse problems. Dr. Colby remained at Talbott *227 until her discharge on November 20, 2004. US 935.

Her physical and psychological intake exams, supervised by Michael Wilkerson, M.D. (“Dr. Wilkerson”), revealed a number of health issues. First, and most obviously, Dr. Colby suffered from opioid dependence. US 935. Staff physicians also diagnosed Dr. Colby with dysthymic disorder, a history of major depression, and obsessive compulsive personality traits. US 936. Further, Dr. Colby reported that her back pain from her degenerative disc disease rated a 6 out of 10 on the Mano-ski’s pain scale. US 940. During her time at Talbott, Dr. Colby began engaging in a rigorous, 2-3 hours per day exercise program, that by the time of her discharge had reduced her back pain to a 1 or 2 out of 10. US 937, 940. Her mental health improved markedly as well. Dr. Colby engaged in daily group meetings to discuss her addiction, and asked and received permission to cease taking the antidepressant drug Zoloft, which she had been taking since at least 2003. US 937. Her discharge summary stated that Dr. Colby “explored the idea of returning to school and finding an area of medicine where she would not be exposed to her drug of choice.” US 940. Despite the encouraging signs of progress, Dr. Wilkerson recommended on discharge

that she not return to the practice of medicine for six months to allow her to continue to work on her recovery and stabilize her home situation. The patient will be reevaluated at Talbott Recovery Campus in approximately six months to determine if, at that time, she is ready to return to the practice of medicine.

Id.

C. Dr. Colby’s Application for Long-Term Disability Benefits

On September 24, 2004, while Dr. Colby was still at Talbott, she applied for long-term disability benefits under the plan she purchased from USIC. U.S. 1188-89. In general terms 2

Free access — add to your briefcase to read the full text and ask questions with AI

Related

O'Shea v. UPS Retirement Plan
115 F. Supp. 3d 138 (D. Massachusetts, 2015)
Kindelan v. Disability Management Alternatives, LLC
706 F. Supp. 2d 210 (D. Rhode Island, 2010)
Colby v. Assurant Employee Benefits
635 F. Supp. 2d 88 (D. Massachusetts, 2009)
Berry v. Paul Revere Life Insurance Co.
21 So. 3d 385 (Louisiana Court of Appeal, 2009)

Cite This Page — Counsel Stack

Bluebook (online)
603 F. Supp. 2d 223, 2009 U.S. Dist. LEXIS 24419, 2009 WL 756974, Counsel Stack Legal Research, https://law.counselstack.com/opinion/colby-v-assurant-employee-benefits-mad-2009.